3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Melanoma
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Squamous Cell
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Radiotherapy
5
Mitomycin
5
Fluorouracil
5
Watchful Waiting
3
Paclitaxel
3
Nivolumab
3
Cisplatin
3
Vaccines
2
Radiation
2
Observation
2
Light Coagulation
2
Carboplatin
2
Capecitabine
2
pembrolizumab
1
nanocis
1
cemiplimab
1
atezolizumab
1
X-Rays
1
Vaccines, Synthetic
1
Technetium-99
1
Taxes
1
Specimen Handling
1
Sigmoidoscopy
1
Proctoscopy
1
Phantoms, Imaging
1
Papillomavirus Vaccines
1
Octreotide
1
Neoadjuvant Therapy
1
Mitomycins
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Anus Neoplasms
×
nanocis
×
Clear all
NCT02997553
2023-01-09
GASVERT
Institut de Cancérologie de Lorraine
Phase 3
Completed
744 enrolled